Table 2 MMR protein deficiency/proficiency in the NLR groups

From: Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour

  

NLR

 
 

Total

<5

⩾5

P -value a

hMLH-1

Negative

45 (12.6%)

37 (13.7%)

8 (9.1%)

0.247

Positive

291 (81.3%)

216 (80.0%)

75 (85.2%)

—

Unknown

22 (6.1%)

17 (6.3%)

5 (5.7%)

—

hMSH-2

Negative

12 (3.4%)

8 (3.0%)

4 (4.5%)

0.489

Positive

326 (91.1%)

246 (91.1%)

80 (90.9%)

—

Unknown

20 (5.6%)

16 (5.9%)

4 (4.5%)

—

Final MMR status

Deficient

55 (15.4%)

44 (16.3%)

11 (12.5%)

0.356

Proficient

286 (79.9%)

212 (78.5%)

74 (84.1%)

—

Unknown

17 (4.7%)

14 (5.2%)

3 (3.4%)

 
  1. Abbreviations: NLR=neutrophil-to-lymphocyte ratio; MMR=mismatch repair.
  2. aχ2-test.
Back to article page